| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |